Early chimerism threshold predicts sustained engraftment and NK-cell tolerance in prenatal allogeneic chimeras.
The failure of engraftment in human cases of in utero hematopoietic cell transplantation (IUHCT) in which no immunodeficiency exists suggests the presence of an unrecognized fetal immune barrier. A similar barrier in murine IUHCT appears to be dependent on the chimerism level and is poorly explained by a lack of T-cell tolerance induction. Therefore, we studied the effect of the chimerism level on engraftment and host natural killer (NK)-cell education in a murine model of IUHCT. The dose of transplanted cells was found to exhibit a strong correlation with both the engraftment rate and chimerism level. More specifically, a threshold level of initial chimerism (> 1.8%) was identified that predicted durable engraftment for allogeneic IUHCT, whereas low initial chimerism (< 1.8%) predicted a loss of engraftment. NK cells taken from chimeras above the "chimerism threshold" displayed durable calibration of alloresponsive Ly49A receptors and tolerance to donor antigens. Depletion of recipient NK cells stabilized engraftment in low-level chimeras (< 1.8%). These studies illustrate the importance of the early chimerism threshold in predicting long-term engraftment and host NK-cell tolerance after in utero transplantation.
Durkin
Emily T
ET
Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, USA.
Jones
Kelly A
KA
Rajesh
Deepika
D
Shaaban
Aimen F
AF
D000818:Animals; D005260:Female; D005315:Fetal Diseases / Q000628:therapy; D005333:Fetus / Q000601:surgery*; D006085:Graft Survival; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D007108:Immune Tolerance; D007694:Killer Cells, Natural / Q000276:immunology*; D051379:Mice; D023421:Models, Animal; D055650:NK Cell Lectin-Like Receptor Subfamily A; D011247:Pregnancy; D018183:Transplantation Chimera; D014184:Transplantation, Homologous
C527088:Klra1 protein, mouse; D055650:NK Cell Lectin-Like Receptor Subfamily A
Blood. 2002 Mar 1;99(5):1870-2
11861310
J Lab Clin Med. 2000 Sep;136(3):224-35
10985501
J Surg Res. 1998 Jun;77(1):1-5
9698523
Blood. 1997 Oct 15;90(8):3222-9
9376606
Blood. 1993 May 15;81(10):2566-71
8098231
J Immunol Methods. 2004 Nov;294(1-2):15-22
15604012
J Exp Med. 1992 Apr 1;175(4):1055-66
1372642
Transplantation. 2005 Jun 15;79(11):1607-14
15940052
J Immunol. 1979 Jan;122(1):291-5
310832
J Exp Med. 1997 Aug 4;186(3):353-64
9236187
Stem Cells. 2003;21(3):304-14
12743325
Blood. 2005 Sep 15;106(6):2215-20
15928035
J Exp Med. 1971 Dec 1;134(6):1513-28
4942407
Blood. 2006 Dec 1;108(12):3824-33
16902150
J Immunol. 1999 Jun 15;162(12):6976-80
10358137
Transplantation. 1995 Feb 15;59(3):395-401
7871570
J Immunol. 2000 Dec 15;165(12):6922-32
11120818
J Exp Med. 1998 Feb 16;187(4):609-18
9463411
Science. 1994 Feb 4;263(5147):674-6
8303275
Thymus. 1987;10(1-2):57-73
3124305
Stem Cells. 2004;22(5):759-69
15342940
Int Immunol. 1998 Dec;10(12):1943-55
9885916
Immunol Today. 1989 Mar;10(3):87-91
2472811
Fetal Diagn Ther. 1996 Jul-Aug;11(4):241-8
8823603
Bone Marrow Transplant. 2000 Jan;25(2):135-41
10673670
J Immunol. 1999 Jul 1;163(1):212-6
10384118
Nat Med. 1995 Dec;1(12):1268-73
7489407
Stem Cells. 2007 Mar;25(3):646-54
17124009
Bone Marrow Transplant. 2005 Mar;35(6):537-47
15665844
Transplantation. 2001 Feb 15;71(3):359-68
11233894
J Immunol Methods. 2003 Oct 1;281(1-2):65-78
14580882
Blood Cells. 1994;20(2-3):348-50
7749115
Leukemia. 2005 May;19(5):835-40
15744340
Am J Obstet Gynecol. 1991 Jan;164(1 Pt 1):218-30
1670910
J Immunol. 2003 Jun 1;170(11):5398-405
12759414
Exp Hematol. 2006 Mar;34(3):359-68
16543070
Pediatrics. 1979 Nov;64(5 Pt 2 Suppl):795-802
41216
Fetal Diagn Ther. 2000 Mar-Apr;15(2):71-8
10720869
Eur J Immunol. 1986 Oct;16(10):1283-8
3095126
J Matern Fetal Med. 1998 Nov-Dec;7(6):296-303
9848696
Transplantation. 1993 Dec;56(6):1460-7
8279020
J Immunol. 1999 Dec 1;163(11):5896-905
10570275
J Immunol. 2005 Sep 15;175(6):3753-61
16148121
J Immunol. 1998 Mar 1;160(5):2197-206
9498758
Immunity. 2000 Jul;13(1):143-53
10933402
Eur J Immunol. 2002 Mar;32(3):868-78
11870631
Transplantation. 1991 Jul;52(1):1-10
1858135
J Immunol. 1995 Jan 15;154(2):633-43
7814872
J Immunol. 1997 Jan 1;158(1):112-9
8977181
J Exp Med. 1998 Sep 7;188(5):973-8
9730898
Cell Mol Immunol. 2007 Oct;4(5):377-82
17976318
Semin Immunol. 1995 Apr;7(2):109-19
7579193
Nat Med. 1997 Jul;3(7):783-7
9212108
J Exp Med. 1996 Nov 1;184(5):2037-41
8920892
Cancer Control. 2004 Mar-Apr;11(2):105-18
15024347
J Immunol. 2003 Sep 15;171(6):3270-7
12960357
Eur J Immunol. 1998 Jan;28(1):47-56
9485185
Immunol Rev. 1993 Jun;133:93-104
8225373
Blood. 2002 Aug 1;100(3):804-12
12130490
J Immunol. 1998 Dec 1;161(11):6133-8
9834098
Blood. 2002 Sep 15;100(6):2225-34
12200389
Eur J Immunol. 2001 Nov;31(11):3370-9
11745355
J Immunol. 1999 Sep 1;163(5):2628-33
10453002
J Pediatr Surg. 1999 May;34(5):726-9; discussion 729-30
10359172